Your browser doesn't support javascript.
loading
The radiotherapy quality assurance gap among phase III cancer clinical trials.
Corrigan, Kelsey L; Kry, Stephen; Howell, Rebecca M; Kouzy, Ramez; Jaoude, Joseph Abi; Patel, Roshal R; Jhingran, Anuja; Taniguchi, Cullen; Koong, Albert C; McAleer, Mary Fran; Nitsch, Paige; Rödel, Claus; Fokas, Emmanouil; Minsky, Bruce D; Das, Prajnan; Fuller, C David; Ludmir, Ethan B.
Afiliación
  • Corrigan KL; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: KLCorrigan@mdanderson.org.
  • Kry S; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: SFKry@mdanderson.org.
  • Howell RM; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: RHowell@mdanderson.org.
  • Kouzy R; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: RKouzy@mdanderson.org.
  • Jaoude JA; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: JBabi@mdanderson.org.
  • Patel RR; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: roshal.r.patel@kp.org.
  • Jhingran A; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: AJhingra@mdanderson.org.
  • Taniguchi C; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: CTaniguchi@mdanderson.org.
  • Koong AC; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: AKoong@mdanderson.org.
  • McAleer MF; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: MFMcalee@mdanderson.org.
  • Nitsch P; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: PLNitsch@mdanderson.org.
  • Rödel C; University of Frankfurt, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany. Electronic address: ClausMichael.Roedel@kgu.de.
  • Fokas E; University of Frankfurt, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany. Electronic address: Emmanouil.Fokas@kgu.de.
  • Minsky BD; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: BMinsky@mdanderson.org.
  • Das P; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: PrajDas@mdanderson.org.
  • Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: CDFuller@mdanderson.org.
  • Ludmir EB; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: EBLudmir@mdanderson.org.
Radiother Oncol ; 166: 51-57, 2022 01.
Article en En | MEDLINE | ID: mdl-34838891
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncología por Radiación / Neoplasias Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncología por Radiación / Neoplasias Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda